Avenue Therapeutics, Inc., a Fortress Biotech Company, is a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes products for use in acute healthcare or hospital settings.  Avenue’s lead product candidate is intravenous (IV) tramadol for the management of post-operative pain.  The company plans to initiate a Phase III development program of IV tramadol in 2017. Avenue is headquartered in New York City.

Contact Information

Avenue Therapeutics, Inc.
2 Gansevoort Street
9th Floor
New York, NY 10014

Investor Relations

Lucy Lu, M.D., CEO